Építés alatt – nem éles oldal
Belépés
BefejeződöttFázis nélkül

A Clinical Study to Determine the Safety and Efficacy of An Oral Probiotic Supplementation in the Management of Irritable Bowel Syndrome With Protein Digestion.

A legfontosabb adatok

Ki végzi
NovoBliss Research Pvt Ltd
Hol
India1 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Befejeződött
Résztvevők
18 fő vett részt
Kezdés
2024. nov. 30.
Befejezés
2024. nov. 30.
A vizsgálat típusa
Beavatkozással járó, 2 csoportAz egyik csoport placebót (hatóanyag nélküli szert) kap, összehasonlításként.
A vizsgált kezelések
  • MetBroma
A regiszteradat frissítve
2026. július 31.

Ki vehet részt

Életkor
18 év – 60 év
Nem
Nők és férfiak
Egészséges önkéntesek
Részt vehetnek

A regiszter feltételei, szó szerint

Mind a 18 feltétel megnézéseKevesebb

Ki vehet részt

  • The subject is an adult male or female aged between 18 to 60 years old
  • Clinically diagnosed with irritable bowel syndrome (IBS) based on Rome IV criteria: Abdominal pain at least 4 days per month - over at least 2 months - associated with one or more of the following:; Related to defecation ii. A change in frequency of stool iii. A change in form (appearance) of stool iv. After appropriate evaluation, the symptoms cannot be fully explained by another medical condition
  • The subject is having refrigerator at their home for storage of test treatment
  • The subject is willing to provide written informed consent, comply with the study procedures, and be present for all the visits
  • The subject is willing to abstain from using any other treatments for irritable bowel syndrome during the study period, unless for a medical urgency
  • The subject is in a stable medical condition, not requiring immediate intervention or hospitalization
  • If the subject is female, she is willing to use a highly effective method of contraception throughout the clinical investigation; Females of childbearing potential must practice and maintain an established method of birth control (e.g., IUD, hormonal implant device/injection, birth control pills, diaphragm, condoms with spermicide, partner vasectomy, or abstinence)
  • Non-childbearing potential females who are surgically sterile, post-menopausal for at least 1 year, or have had a tubal ligation, must have been using hormonal contraception for at least 6 months and agree to continue using the same contraception for the study duration

Ki nem vehet részt

  • The subject has used medications that could influence the study outcomes, such as antibiotics, immunosuppressive drugs, and probiotics or prebiotics supplements within the last 4 weeks
  • The subject has participated in other clinical studies or received any investigational agent in the previous 30 days
  • The subject has a history of diagnosis of either hypertension, diabetes, or liver disease
  • The subject has any other significant medical condition that could interfere with the study or pose a risk to the participant
  • The subject has a history of alcohol abuse
  • The subject has other significant gastrointestinal diseases (e.g., Crohn's disease, ulcerative colitis, celiac disease)
  • The subject has any condition that, in the investigator's judgment, would compromise the subject's safety or study integrity
  • The subject has abnormal baseline Haemoglobin (Hb), Complete Blood Count (CBC), Urine Routine/Microscopy (R/M), or Stool Routine/Microscopy (R/M) results that suggest a different pathology than irritable bowel syndrome
  • The subject works in frequent night shifts (working night shifts at least 3 times per week), and refuses to change the lifestyle
  • The subject is either pregnant, lactating, or plans on conceiving during the course of the study

Hol van ez a vizsgálat?

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

This is an open-label, two-arm, prospective, interventional, in-use safety and efficacy study of an oral probiotic supplementation in adult subjects having irritable bowel syndrome.

A vizsgálat 2 csoportja

  • MetBromaA vizsgált kezelés

    Active Ingredients: Bromelain Mode of Usage: Take one slow-release capsule twice a day, after meal with water Dosage Form: Capsule Unit Dose Route of administration: Oral frequency: Twice a day

  • PlaceboPlacebo, összehasonlításként

    Mode of Usage: Take one slow-release capsule twice a day, after meal with water Dosage Form: Capsule Unit Dose Route of administration: Oral frequency: Twice a day

    Kezelés: MetBroma

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
A Preliminary Investigation of the Safety and Effectiveness of Oral Probiotics Supplementation for Management of Irritable Bowel Syndrome: A Randomized, Open Label, Placebo-Arm, Comparative, Interventional, Proof-of-Science Study
A regiszteradat frissítve
2026. július 31.